NephroGenex Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (25)

Latest Posts

About This Stock More About This Stock
NRX Received Positive Scientific Advice For Phase 3 Program In Diabetic Nephropathy
Article By: BioMedReports
Friday, January 9, 2015 5:13 PM EDT
NRX has announced that the Company has received positive Scientific Advice from the European Medicines Agency (EMA) regarding their Phase 3 program with Pyridorin® in diabetic nephropathy.
In this article: NRX
E NephroGenex Soars 200% After Positive Safety Results In Diabetic Kidney Disease
Article By: Terry Chrisomalis
Friday, January 2, 2015 11:23 AM EDT
Pyridorin shows excellent safety in diabetic kidney disease.
In this article: NRX


Latest Tweets for $NRX

No tweets yet!